On Saturday 18 November 2017, world-renowned experts gathered during the annual meeting of the European Cancer Prevention organisation, supported by the Belgian breast cancer campaign Think-Pink. They shared the latest updates on breast cancer prevention by means of vaccination, diet and medication. Curious what those insights are?
Breast cancer remains the first type of cancer in women worldwide. As treatments keep continuously improving, it remains crucial that breast cancer is detected as soon as possible, because early detection can improve a patient’s prognosis. The public breast cancer screening programmes are critically important.
Dr. Odette Patho
Breast cancer screening; now and the future seen from a radiological point of view
(Primary) Prevention is key
Prevention is better than cure. Knowing that 40 % of all breast cancers can be attributed to modifiable risk factors, primary prevention is of vital importance. Maintaining a healthy weight, exercising more, avoiding alcohol, and eating healthy may reduce the general breast cancer risk by 30 %.
Professor Carlo La Vecchia
Professor Artemis Simopoulos
Omega-3 fatty acids and breast cancer
Professor Niva Shapira
Understanding dietary factors in life-long breast cancer prevention
Preventive medication and vaccination
Adjuvant treatments, such as Tamoxifen and aromatase inhibitors, offer preventive protection in the other breast. And even commonly used medication – aspirin, statins, oral antidiabetics and bisphosphonates – reduce breast cancer risk. These may be relatively inexpensive preventive measures for the population.
Professor Jack Cuzick
Professor Gad Rennert
Treatment of chronic diseases and cancer risk
When we turn to existing medication, the yellow fever vaccine also offers protection against breast cancer. Moreover, scientists are developing vaccination as a feasible preventative measure. Promising results are to be expected from the HER2 vaccine and a DNA vaccine.
A trial that considers vaccination that offers the same natural protection provided by an early pregnancy has just been concluded in Belgium, with the support of ECP and Think-Pink.
Professor José Russo
rhCG effects on molecular profiles
Professor Herman Depypere
rhCG treatment in young women with BRCA1&2 germline mutations on intermediate breast cancer risk markers
Professor Jaak Janssens
Vaccination against breast cancer
The future of prevention is identifying individuals with a high breast cancer risk early on. We need to learn from other disciplines and involve GPs in this identification process. Will we find all the answers in our genetic material? We still have a lot to learn in that field. Gene sequencing might be a powerful tool, but for now, we’re still missing pieces of the puzzle.
Professor Olga Golubnitschaja
Innovative strategies of predictive, preventive and personalised medicine in breast cancer management benefiting the patient and healthcare as a whole
Professor Giovanni Corso
Multiple primary non-breast cancers in breast cancer survivors
Professor Erik de Jonge
Progress in treatment of breast cancer
Professor Jaak Janssens
Precision prevention: multi-level genomic risk assessment & life-style monitors
Thanks to Roche for video support